Quarterly due next week. Should make for a really good read. I would say they will be pushing for announcement before that. Lines up with charts for push into next week. Interesting times.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%